We've upgraded AI Search on TaxTMI with two powerful modes:
1. Basic • Quick overview summary answering your query with references• Category-wise results to explore all relevant documents on TaxTMI
2. Advanced • Includes everything in Basic • Detailed report covering: - Overview Summary - Governing Provisions [Acts, Notifications, Circulars] - Relevant Case Laws - Tariff / Classification / HSN - Expert views from TaxTMI - Practical Guidance with immediate steps and dispute strategy
• Also highlights how each document is relevant to your query, helping you quickly understand key insights without reading the full text.Help Us Improve - by giving the rating with each AI Result:
Appellate Tribunal grants relief to pharmaceutical manufacturers, allowing refund claim for exempted goods. The Appellate Tribunal CESTAT AHMEDABAD allowed the appeal, setting aside the rejection of the refund claim for the 6% value of exempted goods cleared for ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Appellate Tribunal grants relief to pharmaceutical manufacturers, allowing refund claim for exempted goods.
The Appellate Tribunal CESTAT AHMEDABAD allowed the appeal, setting aside the rejection of the refund claim for the 6% value of exempted goods cleared for export under Notification No.12/2012-CE. The Tribunal held that the appellants, engaged in pharmaceutical product manufacturing, were not required to reverse the 6% value under Rule 6(6)(v) of C.C.R., 2004, for goods exempted from duty. The decision was based on legal precedents and provisions of the rules, ultimately granting relief to the appellants in line with the Bombay High Court's decision in a similar case.
Issues: Refund claim rejection for 6% value of exempted goods cleared for export under Notification No.12/2012-CE.
Issue Analysis:
1. Refund Claim Rejection: The appellants filed a refund claim for Rs. 7,77,702 for the period 30.9.12 to 25.2.2013, stating that they wrongly paid 6% of the value of exempted goods cleared for export. The claim was rejected, leading to the appeal. The appellants, engaged in pharmaceutical product manufacturing, argued that they cleared Ethamutol HCL under Chapter Heading 29 of CETA, 1985, exempted from duty under Notification No.12/2012-CE. They contended that they were not required to reverse the 6% value under Rule 6(6)(v) of C.C.R., 2004, citing judgments like C.C.E. Aurangabad Vs. Jolly Board Ltd. and others to support their claim.
2. Legal Arguments: The advocate for the appellants emphasized that they had followed the necessary procedures for clearing the exempted goods for export and that the eligibility for CENVAT credit on such goods was well-established by various High Court judgments. The Revenue, represented by the A.R., supported the findings of the Commissioner (Appeals) in rejecting the refund claim.
3. Judgment and Analysis: The Member (Judicial) analyzed the issue in light of previous judgments and the provisions of Rule 6(6) of 2004 Rules. Referring to the Hon’ble Bombay High Court's decision in Sharp Menthol India Ltd.’s case, it was concluded that the appellants were not required to discharge the 6% value of the exported goods exempted from duty. The impugned order was deemed devoid of merit, leading to its setting aside and allowing the appeal with consequential relief, if any, as per law.
This detailed analysis of the legal judgment highlights the key issues, legal arguments, and the final decision made by the Appellate Tribunal CESTAT AHMEDABAD regarding the rejection of the refund claim for the 6% value of exempted goods cleared for export under Notification No.12/2012-CE.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.